Search

Lysocardiolipin acyltransferase (LYCAT), a cardiolipin (CL)-remodeling enzyme, is crucial for maintaining normal mitochondrial function and vascular development. Despite the well-characterized role for LYCAT in the regulation of mitochondrial dynamics, its involvement in lung cancer, if any, remains incompletely understood. In this study, in silico analysis of TCGA lung cancer data sets revealed a significant increase in LYCAT expression, which was later corroborated in human lung cancer tissues and immortalized lung cancer cell lines via indirect immunofluorescence and immunoblotting, respectively. Stable knockdown of LYCAT in NSCLC cell lines not only reduced CL and increased monolyso-CL levels but also reduced in vivo tumor growth, as determined by xenograft studies in athymic nude mice. Furthermore, blocking LYCAT activity using a LYCAT mimetic peptide attenuated cell migration, suggesting a novel role for LYCAT activity in promoting NSCLC. Mechanistically, the pro-proliferative effects of LYCAT were mediated by an increase in mitochondrial fusion and a G(1)/S cell cycle transition, both of which are linked to increased cell proliferation. Taken together, these results demonstrate a novel role for LYCAT in promoting NSCLC and suggest that targeting LYCAT expression or activity in NSCLC may provide new avenues for the therapeutic treatment of lung cancer.

We proposed over one decade ago that age-related muscle weakness and not the loss of muscle size is the principal contributor to disability. In searching for cellular and molecular explanations for this weakness that exceeds the loss of muscle mass, we found that elements of contractile force generation in skeletal muscle are dependent on store-operated Ca2+ entry (SOCE) and that this capacity is lost in aging skeletal muscle. This altered SOCE is directly associated with reduced content of mitsugumin 29 (MG29), a synaptophysin family protein (SYPL2) containing a MARVEL domain involved in cholesterol binding and formation of oligomers of these proteins. MG29 is essential for the formation of the transverse-tubule system and efficient SOCE, creating a link between reduced MG29 expression in aged muscle and the development of muscle dysfunction in sarcopenia as our previous data demonstrate that aspects of aged skeletal muscle are present in young mg29-/- muscle. Here we test how the loss of MG29 affects the phospholipid composition of skeletal muscle fibers and if producing similar changes in muscle fibers can influence SOCE activity. Lipidomic analysis of young mg29-/- skeletal muscle showed decreased cholesterol content and altered levels of various phospholipid species compared to young control muscle. To simulate the reduced cholesterol content observed in mg29-/- muscle we partially extracted it from mature C2C12 myotubes with methyl-β-cyclodextrin (MCD) and then measured SOCE in these myotubes. Reduced SOCE was observed following MCD extraction, similar to the limited SOCE we previously observed in young mg29-/- and wild-type aged muscle fibers. Further studies will determine if mutation of conserved residues in the MARVEL domain of MG29 modulate SOCE function in, and the lipid composition of, skeletal muscle cells.